ISSN: 1868-6958

Journal Home

Cancer Nanotechnology Q2 Unclaimed

Springer Science + Business Media United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Nanotechnology is a journal indexed in SJR in Oncology and Biomedical Engineering with an H index of 36. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 1490 €. The scope of the journal is focused on nanostructures, nanoscale processes, cancer. It has an SJR impact factor of 0,671 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,671.

Type: Journal

Type of Copyright: CC BY + CC0

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Biomedical Engineering (Q2) Pharmaceutical Science (Q2) Physical and Theoretical Chemistry (Q2) Oncology (Q3)

Price

1490 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,671

SJR Impact factor

36

H Index

83

Total Docs (Last Year)

90

Total Docs (3 years)

4754

Total Refs

399

Total Cites (3 years)

89

Citable Docs (3 years)

4.21

Cites/Doc (2 years)

57.28

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

International Journal of Oncology Q2
BMC Cancer Q2
Cancer Epidemiology Q2
Frontiers in Oncology Q2
Journal of Geriatric Oncology Q2

Compare this journals

Aims and Scope

Nanostructures Nanoscale processes Cancer

Best articles by citations

Using water-soluble C60 fullerenes in anticancer therapy

Bio-conjugation of antioxidant peptide on surface-modified gold nanoparticles: a novel approach to enhance the radical scavenging property in cancer cell

C60 fullerene and its nanocomplexes with anticancer drugs modulate circulating phagocyte functions and dramatically increase ROS generation in transformed monocytes

Thermo-optical analysis and selection of the properties of absorbing nanoparticles for laser applications in cancer nanotechnology

PLGA nanoparticles loaded with etoposide and quercetin dihydrate individually: in vitro cell line study to ensure advantage of combination therapy

Use of a lipid nanoparticle system as a Trojan horse in delivery of gold nanoparticles to human breast cancer cells for improved outcomes in radiation therapy

Nanotechnology and cancer: improving real-time monitoring and staging of bladder cancer with multimodal mesoporous silica nanoparticles

Facile synthesis of biocompatible gold nanoparticles from Vites vinefera and its cellular internalization against HBL-100 cells

Apoptosis-induced anticancer effect of transferrin-conjugated solid lipid nanoparticles of curcumin

In vitro anticancer activity of folate-modified docetaxel-loaded PLGA nanoparticles against drug-sensitive and multidrug-resistant cancer cells

Effective cellular internalization of silica-coated CdSe quantum dots for high contrast cancer imaging and labelling applications

Nanobio applications of quantum dots in cancer: imaging, sensing, and targeting

SHOW MORE ARTICLES

Modulation of cytotoxic and genotoxic effects of nanoparticles in cancer cells by external magnetic field

Could nanoparticle corona characterization help for biological consequence prediction?

Anti-cancer studies of noble metal nanoparticles synthesized using different plant extracts

Effects and side effects of plasmonic photothermal therapy in brain tissue

Important parameters for optimized metal nanoparticles-aided electromagnetic field (EMF) effect on cancer

Cell localisation of gadolinium-based nanoparticles and related radiosensitising efficacy in glioblastoma cells

Enhanced nanoparticle delivery exploiting tumour-responsive formulations

Gazelles, unicorns, and dragons battle cancer through the Nanotechnology Startup Challenge

Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer

Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers

Development of in vitro gene delivery system using ORMOSIL nanoparticle: Analysis of p53 gene expression in cultured breast cancer cell (MCF-7)

Antileukemic potential of PEGylated gold nanoparticle conjugated with protein toxin (NKCT1) isolated from Indian cobra (Naja kaouthia) venom